What's in SIGA Technologies's pipeline?

SIGA Technologies has 7 drugs in our index: 4 marketed, 0 filed, 0 in Phase 3, 0 in Phase 2, 3 in Phase 1.

Which companies overlap with SIGA Technologies's portfolio?

Top competitors by shared drug class: Genzyme, a Sanofi Company, Sanofi, Shire, Tanabe Pharma Corporation, USRC Kidney Research.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/siga-technologies.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-14 · How we verify

SIGA Technologies — Portfolio Competitive Intelligence Brief

SIGA Technologies pipeline: 4 marketed, 0 filed, 0 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

4 marketed 0 filed 0 Phase 3 0 Phase 2 3 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
sevelamer carbonate oral tablet	sevelamer carbonate oral tablet	marketed
Lanthanum Carbonate Chewable Tablet	Lanthanum Carbonate Chewable Tablet	marketed	Phosphate binder	Dietary phosphate (non-receptor mechanism)	Nephrology
Smallpox and Mpox Vaccine	Smallpox and Mpox Vaccine	marketed	Live attenuated viral vaccine / Recombinant viral vaccine		Immunology / Infectious Disease
TPOXX	TPOXX	marketed	Orthopoxvirus protein synthesis inhibitor	Orthopoxvirus p37 protein	Infectious Disease / Virology

Therapeutic area mix

Immunology / Infectious Disease · 1
Infectious Disease / Virology · 1
Nephrology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

Genzyme, a Sanofi Company · 1 shared drug class
Sanofi · 1 shared drug class
Shire · 1 shared drug class
Tanabe Pharma Corporation · 1 shared drug class
USRC Kidney Research · 1 shared drug class
University of Colorado, Denver · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for SIGA Technologies:

Cite this brief

Drug Landscape (2026). SIGA Technologies — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/siga-technologies. Accessed 2026-05-14.